Cite
Clopidogrel Inhibits CYP2C19-Dependent Hydroxylation of Omeprazole Related to CYP2C19 Genetic Polymorphisms.
MLA
Chen, B. L., et al. “Clopidogrel Inhibits CYP2C19-Dependent Hydroxylation of Omeprazole Related to CYP2C19 Genetic Polymorphisms.” Journal of Clinical Pharmacology, vol. 49, no. 5, May 2009, pp. 574–81. EBSCOhost, https://doi.org/10.1177/0091270009333016.
APA
Chen, B. L., Chen, Y., Tu, J. H., Li, Y. L., Zhang, W., Li, Q., Fan, L., Tan, Z. R., Hu, D. L., Wang, D., Wang, L. S., OuYang, D. S., & Zhou, H. H. (2009). Clopidogrel Inhibits CYP2C19-Dependent Hydroxylation of Omeprazole Related to CYP2C19 Genetic Polymorphisms. Journal of Clinical Pharmacology, 49(5), 574–581. https://doi.org/10.1177/0091270009333016
Chicago
Chen, B. L., Y. Chen, J. H. Tu, Y. L. Li, W. Zhang, Q. Li, L. Fan, et al. 2009. “Clopidogrel Inhibits CYP2C19-Dependent Hydroxylation of Omeprazole Related to CYP2C19 Genetic Polymorphisms.” Journal of Clinical Pharmacology 49 (5): 574–81. doi:10.1177/0091270009333016.